Brooks Laboratories Ltd. Share Price & Stock Analysis

Brooks Laboratories Ltd. (NSE: BROOKS, BSE: 533543) is a Mumbai, Maharashtra-based company in the Life Sciences Tools and Services industry. With a market capitalisation of ₹198 Cr, it ranks #2,661 by market cap among the 6,197 Indian listed companies on FinBizNet, and #5 of 10 in Life Sciences Tools and Services. At ₹67.50 (as of 19 Nov 2026), the share price is 37.9% below its 52-week high of ₹108.70 and 86.0% above its 52-week low of ₹36.30. The share price is down 34.2% over one year and up 13.9% over three months.

Key Metrics

Current Price₹67.50
Market Cap₹198 Cr
NSE SymbolBROOKS
BSE Code533543
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services
Sub-IndustryLife Sciences Tools and Services
P/E Ratio7.9
Return on Equity22.28%
Return on Assets2.77%
52-Week Range₹36.30 – ₹108.70
1-Year Price Change-34.2%
3-Month Price Change+13.9%
Beta (1Y)1.07
HeadquartersMumbai, Maharashtra
Websitewww.brookslabs.net

Latest Quarterly Results — Q2 FY27

Revenue₹19 Cr
Net Profit₹68 Cr
Net Margin351.2%
EPS (Basic)₹22.95
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Brooks Laboratories Ltd. Quarterly Revenue and Profit Trend

Brooks Laboratories Ltd. reported revenue of ₹19 Cr in Q2 FY27, down 17.9% from ₹23 Cr in Q2 FY26 and down 16.2% from ₹23 Cr in Q1 FY27. It posted a net profit of ₹68 Cr for the quarter, against a net profit of ₹8 Cr in Q2 FY26 (up 747.2%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹17 Cr (Q3 FY26) to ₹26 Cr (Q1 FY26). The company reported a net loss in 2 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹19 Cr₹68 Cr351.2%
Q1 FY27₹23 Cr−₹2 Cr−7.8%
Q4 FY26₹20 Cr₹2 Cr7.5%
Q3 FY26₹17 Cr₹6 Cr33.2%
Q2 FY26₹23 Cr₹8 Cr34.0%
Q1 FY26₹26 Cr₹10 Cr37.6%
Q4 FY25₹23 Cr−₹1 Cr−6.3%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 52.62% of Brooks Laboratories Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 53.1% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).

About Brooks Laboratories Ltd.

Brooks Laboratories Limited provides contract development and manufacturing services for pharmaceutical companies in India and internationally. The company’s product portfolio includes liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; B-Lactam and cephalosporin tablets, dry powder syrups, and injections; general, liquid, and dry powder injections; formulations for antibiotics, pain management, and controlled drugs; and oncology products and hormonal injections, etc. It also provides regulatory compliance, custom branding and packaging, scalable production, and end-to-end support services. The company serves government health programs and public sector institutions, hospitals and medical colleges, defense and railways, corporate healthcare, and NGOs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan Nigeria, Lebanon, Mauritius, Sudan, Madagascar, DR Congo, Mozambique, LATAM, and

Products and Services

1. Pharmaceuticals-This segment is engaged in manufacturing various pharmaceutical formulations.

Business Segments

1. Trading-3.3% 2. Manufacturing-96.7%

Brooks Laboratories Ltd. vs Peers — Life Sciences Tools and Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Indegene Ltd₹14,840 Cr40.213.94%₹1,122 Cr+26.1%
Suven Life Sciences Ltd.₹7,951 Crn/m-78.80%₹1 Cr+51.8%
Vimta Labs Ltd₹2,259 Cr29.518.55%₹112 Cr-26.8%
Tarsons Products Limited₹1,730 Cr114.92.26%₹124 Cr+25.7%
Brooks Laboratories Ltd.₹198 Cr7.922.28%₹19 Cr-34.2%
Bilcare Ltd.₹194 Cr108.3-5.21%——
Jeevan Scientific Technology Ltd₹176 Cr129.41.68%—+42.3%
Vivo Bio Tech Ltd.₹37 Crn/m-2.00%₹14 Cr-55.7%
Dr. Habeebbullal Life Sciences Ltd₹26 Crn/m-68.79%—-45.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Brooks Laboratories Ltd.?

Brooks Laboratories Ltd. is trading at ₹67.50, with a market capitalisation of ₹198 Cr.

Which sector does Brooks Laboratories Ltd. belong to?

Brooks Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).

What are the key financial ratios of Brooks Laboratories Ltd.?

Brooks Laboratories Ltd. has a P/E of 7.9 and a return on equity of 22.28%.

What is the stock symbol of Brooks Laboratories Ltd.?

Brooks Laboratories Ltd. is listed on the NSE under the symbol BROOKS and on the BSE under the scrip code 533543.

How has Brooks Laboratories Ltd.'s share price moved over the past year?

Brooks Laboratories Ltd.'s share price is down 34.2% over one year and up 13.9% over three months. Its 52-week range is ₹36.30 to ₹108.70.

What were Brooks Laboratories Ltd.'s latest quarterly results?

In Q2 FY27, Brooks Laboratories Ltd. reported revenue of ₹19 Cr and net profit of ₹68 Cr, with basic EPS of ₹22.95 (consolidated, parsed from the company's exchange filing).

How have Brooks Laboratories Ltd.'s revenue and profit changed over the past year?

Brooks Laboratories Ltd. reported revenue of ₹19 Cr in Q2 FY27, down 17.9% from ₹23 Cr in Q2 FY26 and down 16.2% from ₹23 Cr in Q1 FY27.

What is the promoter holding in Brooks Laboratories Ltd.?

Promoters held 52.62% of Brooks Laboratories Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 19 Nov 2026. Descriptive market data only — not investment advice.